DK515489A - Dispergerbar laegemiddelformulering - Google Patents

Dispergerbar laegemiddelformulering

Info

Publication number
DK515489A
DK515489A DK515489A DK515489A DK515489A DK 515489 A DK515489 A DK 515489A DK 515489 A DK515489 A DK 515489A DK 515489 A DK515489 A DK 515489A DK 515489 A DK515489 A DK 515489A
Authority
DK
Denmark
Prior art keywords
dispersible
medicinal formulation
formulation
disintegrant
medicinal
Prior art date
Application number
DK515489A
Other languages
English (en)
Other versions
DK170793B1 (da
DK515489D0 (da
Inventor
Lorraine Mary Murphy
Graham Paul Matthews
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK515489D0 publication Critical patent/DK515489D0/da
Publication of DK515489A publication Critical patent/DK515489A/da
Application granted granted Critical
Publication of DK170793B1 publication Critical patent/DK170793B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DK515489A 1988-10-18 1989-10-17 Dispergerbar lægemiddelformulering og fremgangsmåde til fremstilling heraf DK170793B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8824392 1988-10-18
GB888824392A GB8824392D0 (en) 1988-10-18 1988-10-18 Dispersible formulation

Publications (3)

Publication Number Publication Date
DK515489D0 DK515489D0 (da) 1989-10-17
DK515489A true DK515489A (da) 1990-04-19
DK170793B1 DK170793B1 (da) 1996-01-22

Family

ID=10645384

Family Applications (1)

Application Number Title Priority Date Filing Date
DK515489A DK170793B1 (da) 1988-10-18 1989-10-17 Dispergerbar lægemiddelformulering og fremgangsmåde til fremstilling heraf

Country Status (19)

Country Link
EP (1) EP0365480B1 (da)
JP (1) JP2795924B2 (da)
KR (1) KR0151131B1 (da)
AT (1) ATE79538T1 (da)
AU (1) AU626924B2 (da)
CA (1) CA2000763C (da)
DE (1) DE68902531T2 (da)
DK (1) DK170793B1 (da)
ES (1) ES2052065T3 (da)
FI (1) FI94925C (da)
GB (1) GB8824392D0 (da)
GR (1) GR3006304T3 (da)
IE (1) IE62557B1 (da)
IL (1) IL91949A (da)
NZ (1) NZ231023A (da)
PH (1) PH30526A (da)
PT (1) PT92002B (da)
SA (1) SA90100079B1 (da)
ZA (1) ZA897853B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
DE69739967D1 (de) * 1996-06-14 2010-09-30 Kyowa Hakko Kirin Co Ltd Eine im Mund schnell zerfallende Tablette
EP0839526A3 (en) 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
US6312724B1 (en) 1997-04-04 2001-11-06 Isa Odidi Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof
WO1999059544A2 (en) 1998-05-18 1999-11-25 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
CA2328703C (en) * 1998-06-11 2007-10-30 Pharmacia & Upjohn Company Delavirdine tablet formulation
CA2525555A1 (en) 1998-07-28 2000-02-10 Takeda Pharmaceutical Company Limited Rapidly disintegrable solid preparation
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JO3352B1 (ar) 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
TW201113266A (en) * 2009-09-02 2011-04-16 Ziopharm Oncology Inc Pharmaceutical formulations for indibulin
JP5309262B2 (ja) 2009-12-02 2013-10-09 アプタリス ファーマ リミテッド フェキソフェナジン・マイクロカプセル及びそれを含む組成物
EP2704689B1 (en) 2012-04-19 2018-11-28 Glatt AG Taste-masked pharmaceutical compositions containing diclofenac
DE202022100544U1 (de) 2022-01-31 2022-02-16 Ranjitsing Babasing Bayas Neue orale Streifen- oder Dünnfilmform von Diclofenac-Natrium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200178B (it) 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
CH675537A5 (da) * 1988-03-25 1990-10-15 Ciba Geigy Ag

Also Published As

Publication number Publication date
AU4297089A (en) 1990-04-26
PH30526A (en) 1997-06-13
EP0365480B1 (en) 1992-08-19
DK170793B1 (da) 1996-01-22
DE68902531D1 (de) 1992-09-24
IE62557B1 (en) 1995-02-08
JP2795924B2 (ja) 1998-09-10
KR0151131B1 (ko) 1998-10-15
CA2000763C (en) 2000-11-14
GR3006304T3 (da) 1993-06-21
PT92002B (pt) 1995-06-30
DE68902531T2 (de) 1993-04-08
FI94925B (fi) 1995-08-15
EP0365480A1 (en) 1990-04-25
IE893336L (en) 1990-04-18
FI894899A0 (fi) 1989-10-16
NZ231023A (en) 1991-09-25
FI94925C (fi) 1995-11-27
IL91949A0 (en) 1990-06-10
IL91949A (en) 1993-08-18
KR900005964A (ko) 1990-05-07
AU626924B2 (en) 1992-08-13
SA90100079B1 (ar) 1999-03-21
JPH02164824A (ja) 1990-06-25
ES2052065T3 (es) 1994-07-01
DK515489D0 (da) 1989-10-17
GB8824392D0 (en) 1988-11-23
PT92002A (pt) 1990-04-30
ZA897853B (en) 1992-07-29
ATE79538T1 (de) 1992-09-15
CA2000763A1 (en) 1990-04-18

Similar Documents

Publication Publication Date Title
DK515489A (da) Dispergerbar laegemiddelformulering
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
IT1211484B (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
IL101883A0 (en) Antiviral combinations and pharmaceutical compositions containing them
DK0497158T3 (da) Farmaceutisk tyggegummi med acetylsalicylsyre
FI903153A0 (fi) 11b-aryl-4-estrener, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel.
GR3004863T3 (da)
EP0383481A3 (en) Anesthetic oral compositions
NO933521D0 (no) Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreester samt deres pyridin-n-oksyder, fremgangsmaater for deres fremstilling og deres anvendelse som legemiddel
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
IL87867A (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-3-phenyl-azo-pyridine derivative
DK493887A (da) Buccal formulering
DE69325531D1 (de) Oral anzuwendendes Arzneimittel bestehend aus Ibuprofen
NO950842L (no) Diarylpiperazinoacetamidforbindelser som antimuskariniske midler
ITMI911841A1 (it) Derivati dell'eseridina utili per il trattamento delle malattie associaate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired